Dr. Raviele and Dr. Natale to participate to AFA/Europe AF Patients Day in London!
A key occasion of meetings and debates between worldwide-known specialists and patients suffering from Atrial Fibrillation: that's what AFA Patients Day is. The next edition will be held in London, on November 21, 2011, during the first day of the Europe AF congress, the international event attended by many among the most important experts in this increasingly widespread arrhythmia.
Dr. Antionio Raviele and Dr. Andrea Natale, VeniceArrhythmias' President and Co-President respectively (and holding the same offices at Stop FA's Scientific Committee and at ALFA's Promoting Committee), have been both invited to take part to the prestigious Faculty of the Europe AF congress, along with widely renowned colleagues.
The AFA Patients Days aim at favouring a close interaction between cardiologists, patients and medical professionals, in a process of mutual exchange of significant experiences. Furthermore, the contextualization of a Patients Day within the above mentioned event offers the opportunity to be informed about the latest scientific upgrades, technological innovations and treatment strategies to contrast and prevent Atrial Fibrillation.
Dr. Raviele will chair - along with Dr. Sam Levy - a highly-interesting session on Monday, November 21, at 10.20: USING DRUGS TO TREAT AF: HOW TO CHOOSE? - the session will host contributions by Dr. D. George Wyse, Prof. A. John Camm and Dr. Gregory Lip. On the same day, at 16.45, Dr. Natale will participate into an intriguing Pro / Con Debate, together with Dr. Albert J. Waldo: THIS HOUSE BELIEVES THAT ABLATION SHOULD NOT BE OFFERED TO PATIENTS WITH ASYMPTOMATIC AF.
Download the AFA/Europe AF Patients Day 2011 invitation / program
Further information about AFA Patients Days: www.atrialfibrillation.org.uk
Further information about Europe AF : www.europeaf.com
STOP FA: a successful story! Extensive media coverage of the educational and awareness campaign - plus new 3D video!
Let's say it clear: STOP FA, the educational awareness campaign for the struggle against Atrial Fibrillation, promoted by ALFA (ALiance to Fight Atrial fibrillation) and made possible through the unconditioned contribution of Sanofi, is having a massive success all over Italy.
[Visit the STOP FA website for further information!]
STOP FA going MASSIVE! Great success of the recently launched awareness campaign on Atrial Fibrillation!
STOP FA, the awareness campaign for the struggle against Atrial Fibrillation, promoted by ALFA (ALiance to Fight Atrial fibrillation) and made possible through the unconditioned contribution of Sanofi, is gaining extensive, massive attention by the most important Italian media.
[Visit the STOP FA website for further information!]
STOP FA launch! Dr. Raviele introduces the awareness campaign's guidelines on top Italian TV program!
On May, 2, STOP FA, the awareness campaign for the struggle against Atrial Fibrillation promoted by ALFA (ALiance to Fight Atrial fibrillation) and made possible through the unconditioned contribution of sanofi-aventis, was prestigiously christened as the opening feature on TG 1 Doctors, the top Italian TV programme about the most important protagonists and news in nowadays' medicine and research.
Congratulations to Dr. Luigi Di Biase (Senior Researcher at Texas Cardiac Arrhythmia Institute - St. David's Medical Center, Austin) and Dr. Rong Bai ( Research fellow at Texas Cardiac Arrhythmia Institute - St. David's Medical Center, Austin), who have recently received the Awards for Best Oral Abstract and Best Poster Presentation, respectively, at Cardioryhthm 2011 in Hong Kong.
[read more]
On September, 23, Dr. Raviele was among the main guests of "UnoMattina", the most viewed morning TV show in Italy, broadcasted by Italian main national channel, RAI 1. Dr. Raviele's extensive contribution mainly focused on the great effects of the dronedarone molecule in the treatment of atrial fibrillation, and had so great an impact on viewers that phone calls about the interview kept on arriving even after the end of the program.
[view Dr. Raviele's intervention at UnoMattina]
a cura di Maria Grazia Bongiorni* ed Antonio Raviele**
* Direttore UO Malattie Cardiovascolari II – AOUP, Pisa, Presidente AIAC;
** Direttore Dipartimento Cardiovascolare, Ospedale dell'Angelo, Mestre, Past-President AIAC
Il dronedarone è un nuovo farmaco antiaritmico derivato dall'amiodarone, da cui differisce fondamentalmente per l'assenza di iodio, che è stato recentemente introdotto in commercio per la profilassi delle recidive aritmiche in pazienti con fibrillazione atriale parossistica/persistente. [leggi tutto]
Six leading experts of the field, with just one goal: that of making patients suffering form atrial fibrillation all over the world feel better – for real. Professors Camm, Waldo, Dorian, Hohnloser, Le Heuzey and Raviele talk about Multaq-Dronedarone: because if atrial fibrillation is a call for help, they're here to answer this call... [view the video]
Following his excellent, highly-esteemed work on the dronedarone molecule, Dr. Raviele has been recently invited to participate to a Lectio Magistralis on the sanofi-aventis Foundation Research Day. The lecture is due to be held on November 24, 2010, and will be moderated by Dr. M. M. Gulizia.
On July 13, 2010, at Ospedale dell'Angelo in Venice-Mestre, a press conference was held by VA2011 President, Antonio Raviele, MD – along with other members of the Cardiovascular Department – to present a brand undercutaneous defibrillator – and quite an advanced one.
In a few words, a first step has been made in going from an equipment provided with heart-connected catheters to a totally undercutaneous system – besides that, a more comfortable one, allowing surface ECG-like intervention. And there's more: costs are quite similar to the ones of the previous model (about € 17,000).
As MScope no. 953 reports, VA2011 President, Antonio Raviele, was among those worldwide-known specialists who visited the New York Methodist Hospital, as part of a lecture program organized by Gloria Turrito, M.D., director of electrophysiology. A great occasion to point out progress and key topics in an increasingly growing field... [read more]
